IAG Wealth Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.13K Hold
50
﹤0.01% 461
2026
Q1
$3.14K Hold
50
﹤0.01% 451
2025
Q4
$4.77K Hold
50
﹤0.01% 409
2025
Q3
$4.88K Hold
50
﹤0.01% 431
2025
Q2
$5.37K Hold
50
﹤0.01% 396
2025
Q1
$5.04K Hold
50
﹤0.01% 400
2024
Q4
$4.47K Hold
50
﹤0.01% 429
2024
Q3
$4.19K Hold
50
﹤0.01% 418
2024
Q2
$3.85K Hold
50
﹤0.01% 413
2024
Q1
$3.42K Hold
50
﹤0.01% 389
2023
Q4
$2.89K Hold
50
﹤0.01% 381
2023
Q3
$2.64K Hold
50
﹤0.01% 392
2023
Q2
$2.71K Hold
50
﹤0.01% 399
2023
Q1
$2.5K Hold
50
﹤0.01% 407
2022
Q4
$2.31K Sell
50
-37
-43% -$1.6K ﹤0.01% 395
2022
Q3
$3K Buy
87
+37
+74% +$1.48K ﹤0.01% 376
2022
Q2
$2K Hold
50
﹤0.01% 382
2022
Q1
$2K Hold
50
﹤0.01% 390
2021
Q4
$2K Hold
50
﹤0.01% 372
2021
Q3
$3K Hold
50
﹤0.01% 348
2021
Q2
$3K Hold
50
﹤0.01% 331
2021
Q1
$2K Hold
50
﹤0.01% 338
2020
Q4
$2K Buy
+50
New +$1.8K ﹤0.01% 321

Other funds holding BSX

IAG Wealth Partners's BSX Position: Q2 2026 in Review

IAG Wealth Partners held its Boston Scientific (BSX) position steady in Q2 2026 at 50 shares worth $2.13K. The position accounts for ﹤0.01% of the portfolio, ranked #461.

IAG Wealth Partners first reported a position in BSX in Q4 2020 and has held it in 23 quarters since. The position peaked at $5.37K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • IAG Wealth Partners held 50 shares of Boston Scientific worth $2.13K as of Q2 2026.
  • IAG Wealth Partners left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of IAG Wealth Partners's portfolio in Q2 2026, its #461 holding.
  • IAG Wealth Partners first reported a position in Boston Scientific in Q4 2020 and has held it in 23 quarters since.
  • IAG Wealth Partners's Boston Scientific position peaked at $5.37K in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on IAG Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.